Alpha Crest Capital Management LLC Meridian Bioscience Inc Transaction History

Alpha Crest Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$23.75 - $31.69 $854,002 - $1.14 Million	-35,958 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$19.97 - $26.94 $718,081 - $968,708	35,958 New	35,958 $933,000
Q4 2021 Feb 09, 2022	SELL	$17.46 - $21.61 $207,774 - $257,159	-11,900 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$17.35 - $22.5 $206,465 - $267,750	11,900 New	11,900 $229,000
Q2 2021 Aug 12, 2021	SELL	$18.01 - $28.32 $185,503 - $291,696	-10,300 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$19.76 - $29.89 $203,528 - $307,867	10,300 New	10,300 $270,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.